Molly Harper

Molly Harper

Direktor/Vorstandsmitglied bei CATALYST PHARMACEUTICALS, INC.

Vermögen: 78 288 $ am 30.04.2024

48 Jahre
Health Technology
Consumer Services
Technology Services

Ursprung des Netzwerks ersten Grades von Molly Harper

EinheitArt der EinheitIndustrie
Public Company Pharmaceuticals: Major 20
Public Company Biotechnology 19

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Molly Harper

UnternehmenSektorVerknüpfte PersonenHauptposition
BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Michael Burgess

Tamar Thompson

Corporate Officer/Principal

Corporate Officer/Principal

Information Technology Services

Philip Coelho

Director/Board Member

ROCHE HOLDING AG Pharmaceuticals: Major

Michael Burgess

Corporate Officer/Principal

Pharmaceuticals: Major

Patrick McEnany

Steven Miller

Chief Executive Officer

Chief Tech/Sci/R&D Officer

VERTEX PHARMACEUTICALS INCORPORATED Pharmaceuticals: Major

Lisa Kelly-Croswell

Patricia Hurter

Brendan St Amant

Human Resources Officer

Corporate Officer/Principal

General Counsel

THERMOGENESIS HOLDINGS, INC. Medical Specialties

Philip Coelho

Patrick McEnany

Chief Executive Officer

Director/Board Member

AMARIN CORPORATION PLC Pharmaceuticals: Major

Michael Kalb

Director of Finance/CFO

TARO PHARMACEUTICAL INDUSTRIES LTD. Pharmaceuticals: Major

Michael Kalb

Director of Finance/CFO

BIODELIVERY SCIENCES INTERNATIONAL, INC. Pharmaceuticals: Major

Mary Coleman

Investor Relations Contact

MOMENTA PHARMACEUTICALS, INC. Pharmaceuticals: Major

Richard Shea

Peter Barrett

Director of Finance/CFO

Chairman

HURON CONSULTING GROUP INC. Miscellaneous Commercial Services

Michael Kalb

Comptroller/Controller/Auditor

AGILE THERAPEUTICS, INC. Pharmaceuticals: Major

Mary Coleman

Investor Relations Contact

Miscellaneous Commercial Services

Ed Mathers Mathers

Nick Leschly

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Nick Leschly

Director/Board Member

RA PHARMACEUTICALS, INC. Pharmaceuticals: Major

Ed Mathers Mathers

Aoife Brennan

Chairman

Director/Board Member

Boston University College/University

Richard Shea

Thomas J. Adam

Antoine Awad

Masters Business Admin

Masters Business Admin

Undergraduate Degree

Biotechnology

Michael Burgess

Corporate Officer/Principal

Pharmaceuticals: Major

Richard Shea

Ed Mathers Mathers

Nick Leschly

Aoife Brennan

Director/Board Member

Director/Board Member

Director/Board Member

Chief Executive Officer

The Johns Hopkins University College/University

Gary Ingenito

Jamie Austin

Undergraduate Degree

Graduate Degree

College/University

Peter Barrett

Mary Dooley

Doctorate Degree

Masters Business Admin

Princeton University College/University

Richard Shea

Nick Leschly

Undergraduate Degree

Undergraduate Degree

University of Maryland College/University

Donald Denkhaus

Steven Miller

Masters Business Admin

Undergraduate Degree

Harvard Business School College/University

Peter Barrett

Daniel Rosan

Corporate Officer/Principal

Masters Business Admin

College/University

Gary Ingenito

Steven Miller

Graduate Degree

Doctorate Degree

Pharmaceuticals: Major

Ed Mathers Mathers

Richard Daly

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Peter Barrett

Michael Heffernan

Director/Board Member

Chairman

TREVI THERAPEUTICS, INC. Biotechnology

Ed Mathers Mathers

Michael Heffernan

Director/Board Member

Director/Board Member

University of Illinois College/University

Lisa Kelly-Croswell

Brian Elsbernd

Graduate Degree

Undergraduate Degree

The Royal College of Paediatrics & Child Health College/University

Michael Burgess

Corporate Officer/Principal

The Wharton School of the University of Pennsylvania College/University

Nick Leschly

Masters Business Admin

The Royal College of Physicians College/University

Michael Burgess

Corporate Officer/Principal

2SEVENTY BIO, INC. Pharmaceuticals: Major

Nick Leschly

Chairman

Financial Conglomerates

Michael Burgess

Corporate Officer/Principal

University of Bristol College/University

Michael Burgess

Doctorate Degree

Pharmaceuticals: Major

Michael Burgess

Corporate Officer/Principal

TURNSTONE BIOLOGICS CORP. Biotechnology

Michael Burgess

Chief Tech/Sci/R&D Officer

SPRINGWORKS THERAPEUTICS, INC. Biotechnology

Michael Burgess

Chief Tech/Sci/R&D Officer

Biotechnology

Michael Burgess

Director/Board Member

BIOXCEL THERAPEUTICS, INC. Biotechnology

Mary Coleman

Investor Relations Contact

Bowling Green State University College/University

Mary Coleman

Undergraduate Degree

State University of New York at Albany College/University

Michael Kalb

Undergraduate Degree

Pharmaceuticals: Generic

Michael Kalb

Director of Finance/CFO

CINCOR PHARMA, INC. Pharmaceuticals: Major

Michael Kalb

Director of Finance/CFO

Statistik

International

Vereinigte Staaten 41
Vereinigtes Königreich 5
Irland 2
Israel 2
Mexiko 2

Sektoral

Health Technology 29
Consumer Services 15
Commercial Services 5
Technology Services 2
Finance 2

Operativ

Director/Board Member 136
Corporate Officer/Principal 70
Independent Dir/Board Member 54
President 31
Chairman 31
  1. Börse
  2. Insiders
  3. Molly Harper
  4. Unternehmensverbindungen